Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Neuract** is an investigational topical cream developed by Origin BioMed for short-term relief of neuropathic lower back pain. It was evaluated against placebo in a randomized, double-blind clinical study involving a single approximately 1 mL topical application, with pain effects monitored for up to 8 hours. Publicly available trial information identifies the product and its clinical use, but does not disclose a definitive active-ingredient composition, molecular target, or mechanism of action; therefore, Neuract should not be conflated with the unrelated Colombian Neuract rivastigmine transdermal patch product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neuract.